LIFE: Major shareholding notification

On January 8th 2026, Lacal AS sold 925.000 shares in Lifecare ASA. After thesale, Lacal AS holds 1.000.000 shares in Lifecare ASA, corresponding to aholding of 5,24 percent of the shares and votes in the company.

LIFE: Flagging

Den 8. januar 2026 solgte Lacal AS 925.000 aksjer i Lifecare ASA. Etter salgeteier Lacal AS 1.000.000 aksjer i Lifecare ASA, tilsvarende en andel på 5,24prosent av aksjene og stemmene i selskapet

Lifecare ASA Demonstrates In-Vivo Success of Implantable Glucose Monitoring System

(AWP Alliance News) - Lifecare ASA has announced the first in-vivo confirmation that its fully integrated implantable Continuous Glucose Monitoring (CGM) system functions as intended, using implants from the company's first reproducibly manufactured production batch. The results were generated in the ongoing longevity study LFC-SEN-002 and represent the first real-life operation of the complete implant architecture in living tissue. Early data indicate that the implant produc…

Lifecare confirms reproducible implant tracks glucose in vivo

Lifecare ASA Allocates Subscription Rights in Partially Underwritten Rights Issue

(AWP Alliance News) - Lifecare ASA has announced the allocation of subscription rights in connection with its partially underwritten rights issue. Existing shareholders as of 2 January 2026 have received 10.49 subscription rights per share, rounded down to the nearest whole right. Each subscription right entitles the holder to subscribe for one new share at a price of NOK 0.50 per share. The allocation includes primary insiders and closely associated parties, such as board me…

Lifecare ASA: Mandatory notification of trade – allocation of subscription rights

Lifecare ASA: Commencement of the subscription period for the Rights Issue

Lifecare ASA: Approval and publication of prospectus for Rights Issue

Lifecare ASA CFO Renete Kaarvik Resigns

(AWP Alliance News) - Lifecare ASA has announced that Chief Financial Officer Renete Kaarvik will leave the company for a new position elsewhere. She will remain in her role during a transition period, including the ongoing rights issue, before stepping down. Arrangements are being made to ensure continuity of the CFO function. https://docs.publicnow.com/47C2A5FBAE2F6DA515DA1D6320D3E7A5D4BBE8BE Disclaimer: This news brief was created using generative artificial intelligence. …

Lifecare ASA – CFO transition

Lifecare ASA – Ex. subscription rights today

LIFECARE ASA: Minutes from Extraordinary General Meeting

Lifecare ASA Registers Share Capital Reduction to NOK 1.91 Million

(AWP Alliance News) - Lifecare ASA has registered a reduction in the par value of its shares to NOK 0.10, following a resolution by the Extraordinary General Meeting on 12 November 2025. The company's new share capital is NOK 1,906,097.30, divided into 19,060,973 shares, each with a nominal value of NOK 0.10. https://docs.publicnow.com/188ACFBF8152154D9A954676D5F4555F3BF04E1A Disclaimer: This news brief was created using generative artificial intelligence. Lifecare ASA publis…

Lifecare ASA: New share capital registered

Lifecare Prices Rights Offering to Raise NOK100 Million

01:31 AM EST, 12/31/2025 (MT Newswires) -- Medical technology company Lifecare (LIFE.OL) said Tuesday it priced its rights offering of 200 million new shares at 0.50 Norwegian krone apiece to raise 100 million kroner. Under the offering, shareholders on record as of Jan. 6, 2026, will be eligible for 10.49 subscription rights per share. The offering remains subject to shareholder approval at an extraordinary general meeting to be held on Jan. 2, 2026. DNB Carnegie and SB1 Mar…

Lifecare ASA Announces Issuance of Warrants and Share Rights

(AWP Alliance News) - Lifecare ASA has announced details regarding its proposed partially underwritten rights issue, which grants existing shareholders preferential subscription rights to new shares. Subscribers in the rights issue will receive, at no additional cost, three warrants for every four offer shares allocated and paid for. These warrants will be issued in two series: Warrants Series 1, exercisable from 2 March 2026 to 13 March 2026, and Warrants Series 2, exercisab…

Lifecare ASA: Updated key information relating to the proposed partially underwritten rights issue

Lifecare implants first consistently manufactured implant

Lifecare ASA Announces Date for Extraordinary General Meeting

(AWP Alliance News) - Lifecare ASA, a MedTech company developing next-generation continuous glucose monitoring technology, will hold an Extraordinary General Meeting on 2 January 2026. During the meeting, shareholders will vote on several matters related to a partially underwritten rights issue of new shares, including a share capital increase, the issuance of Warrants Series 1 and Series 2, board authorization to issue shares as an underwriting fee, and the issuance of addit…

LIFECARE ASA: Extraordinary General Meeting

Lifecare · 2024 financial report

Lifecare · 2024-Q3 financial report

Lifecare · 2024-Q2 financial report

Lifecare · 2024-Q1 financial report